Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping.


Journal

Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304

Informations de publication

Date de publication:
10 2019
Historique:
received: 20 05 2019
revised: 31 07 2019
accepted: 04 08 2019
pubmed: 14 8 2019
medline: 7 11 2019
entrez: 13 8 2019
Statut: ppublish

Résumé

To identify predictors of unsuccessful sentinel lymph node (SLN) mapping in patients with apparent early-stage endometrial cancer (EC) undergoing surgical staging with cervical injection of indocyanine green and SLN biopsy. We retrospectively identified consecutive patients with EC with attempted SLN biopsy between June 2014 and June 2016 at our institution. Patients were grouped according to whether they had a successful procedure, defined as the bilateral identification of SLNs, or an unsuccessful procedure, defined as unilateral or no SLN mapping. Logistic regression was used to evaluate predictors of an unsuccessful procedure. Among 327 patients included in the analysis, 256 (78.3%) had a successful procedure and 71 (21.7%) had an unsuccessful procedure (15.0% unilateral SLN mapping, 6.7% no mapping). The rate of successful procedure increased from 57.7% to 83.3% between the first and last quarters of the 2-year study period, which represented the learning curve for the technique. The mean (SD) operative time decreased from 164 (55) to 137 (37) minutes. By multivariable analysis, lysis of adhesions at the beginning of surgery (odds ratio, 3.07; 95% CI, 1.56-6.07) and the presence of enlarged lymph nodes (odds ratio, 4.69; 95% CI, 1.82-12.11) were independently associated with an unsuccessful procedure. Lysis of adhesions at the beginning of surgery and the presence of enlarged lymph nodes independently affect the bilateral detection of SLNs.

Identifiants

pubmed: 31402166
pii: S0090-8258(19)31459-3
doi: 10.1016/j.ygyno.2019.08.008
pii:
doi:

Substances chimiques

Coloring Agents 0
Indocyanine Green IX6J1063HV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-38

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Lucia Tortorella (L)

Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, United States of America; Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.

Jvan Casarin (J)

Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, United States of America.

Francesco Multinu (F)

Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, United States of America.

Serena Cappuccio (S)

Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, United States of America.

Michaela E McGree (ME)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States of America.

Amy L Weaver (AL)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States of America.

Carrie L Langstraat (CL)

Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, United States of America.

Gary L Keeney (GL)

Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, United States of America.

Amanika Kumar (A)

Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, United States of America.

Gian Benedetto Melis (GB)

Division of Gynecology and Obstetrics, University of Cagliari, Cagliari, Italy.

Stefano Angioni (S)

Division of Gynecology and Obstetrics, University of Cagliari, Cagliari, Italy.

Giovanni Scambia (G)

Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.

Andrea Mariani (A)

Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, United States of America.

Gretchen E Glaser (GE)

Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: glaser.gretchen@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH